Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

"Considering the recent market challenges, the share price decline, and the wish from the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Fruergaard Jørgensen have jointly concluded that ...

GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...

Supreme Court Wrestles With Judges’ Power to Freeze Government Actions Nationwide The Supreme Court heard arguments in a case with potentially major implications for the power of federal judges ...

The trial aims to enroll 40 patients with FGFR alterations across the US, who won't need to travel far to receive care.

We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.